Caspase-3 and lymphatic vessels quantification.

<p>Assessment of the levels of caspase-3 in control and SP2024-treated tumor sections. (A) Significant increase (p<0.05) of caspase-3 in the treated tumors in comparison to the untreated tumors (B and C). Representative images of untreated tumor section (B) and treated tumor section (C). (D) Quantification of the lymphatic vasculature in the control group in comparison to the treated group. There was no statistical significance due to the scarcity of lymphatic vasculature but the difference between the two groups was visible on tumor sections. (E and F) Representative images of the control and the treated group respectively.